MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
-17.3%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$76.5M
AUM Growth
+$76.5M
(-53%)
Cap. Flow
-$70.3M
Cap. Flow
% of AUM
-91.79%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$70.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Phathom Pharmaceuticals
PHAT
$864M
| $53.4M | 69.76% | 2,067,861 | – | – |
|
2
Merus
MRUS
$4.98B
| $19.4M | 25.3% | 1,600,000 | – | – |
|
|
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $3.78M | 4.94% | 1,570,000 | – | – |
|
|
THOR
4
DELISTED
Synthorx, Inc. Common Stock
THOR
| – | – | -1,005,184 | Closed | -$70.3M |
|